Obsidian Therapeutics, Inc. (OBX)
10.99
+1.39
(+14.48%)
USD |
NASDAQ |
Nov 06, 10:09
Obsidian Therapeutics Debt to Equity Ratio : 0.0959 for June 30, 2026
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.0959 |
| March 31, 2026 | 0.00 |
| December 31, 2025 | 0.00 |
| September 30, 2025 | -1.03 |
| June 30, 2025 | -1.039 |
| March 31, 2025 | -1.046 |
| December 31, 2024 | -1.051 |
| September 30, 2024 | -1.056 |
| June 30, 2024 | -1.103 |
| March 31, 2024 | -1.130 |
| December 31, 2023 | -1.161 |
| September 30, 2023 | -1.198 |
| June 30, 2023 | -1.301 |
| March 31, 2023 | -1.474 |
| Date | Value |
|---|---|
| December 31, 2022 | -1.279 |
| September 30, 2022 | -1.399 |
| June 30, 2022 | -1.600 |
| March 31, 2022 | -1.853 |
| December 31, 2021 | -2.213 |
| September 30, 2021 | -2.922 |
| June 30, 2021 | -4.855 |
| March 31, 2021 | -6.162 |
| December 31, 2020 | 10.45 |
| September 30, 2020 | 2.540 |
| June 30, 2020 | 1.53 |
| March 31, 2020 | 1.227 |
| December 31, 2019 | 0.6333 |
| September 30, 2019 | 1.574 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Cypherpunk Technologies, Inc. | 0.0003 |
| Cue Biopharma, Inc. | 3.813 |
| Yarrow Bioscience, Inc. | 0.00 |
| Faeth Therapeutics, Inc. | 0.0009 |
| Immuneering Corp. | 0.021 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 51.44M |
| Total Liabilities (Quarterly) | 21.12M |
| Shareholders Equity (Quarterly) | 30.32M |
| Current Ratio | 2.296 |